Sign inJoin waitlistJoin the waitlist

Paul Corn

Chair · University of Texas M D Anderson Cancer Center

Credentials: · · · ·

History

University of Texas M D Anderson Cancer Center
Present
University of Texas M D Anderson Cancer Center
Present

1996-2000 Fellowship Medical Oncology
1996–2000
University of Chicago Hospital
1993–1996
George Washington Univ Sch of Med
1989–1993

Research

A gene hypermethylation profile of human cancer
Cancer Research · 2001 · 1,656 citations
Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3
Journal of Clinical Oncology · 2016 · 1,422 citations
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
Review · Oncogene · 2013 · 681 citations

Christopher Logothetis
57 papers
Ana Aparicio
42 papers
Patricia Troncoso
32 papers
Nizar Tannir
26 papers
Sumit Subudhi
22 papers
Eric Jonasch
19 papers
EE
Eleni Efstathiou
15 papers
John Araujo
14 papers
Matthew Campbell
13 papers · 2 as a fellow
Chad Tang
12 papers
Patrick Pilié
12 papers
Pavlos Msaouel
12 papers · 7 as a fellow

Grants

Comprehensive Assessment of Cancer Theranostics Response
National Cancer Institute · R44
PI · $2M · Aiq Global Inc
2023–2026
Regulation of the von Hippel-Lindau Protein
National Cancer Institute · K08
Contact PI · $646.1K · University of Tx Md Anderson Can Ctr
2003–2009

Clinical trials

Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Principal investigator · Recruiting · Phase 3
SWOG Cancer Research Network
2024–2034
Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer
Principal investigator · Terminated · Phase 2
M.D. Anderson Cancer Center
2021–2026
Abiraterone Acetate, Prednisone, and Apalutamide in Treating Patients With Hormone-Naive Metastatic Prostate Cancer
Principal investigator · Active not recruiting · Phase 2
M.D. Anderson Cancer Center
2019–2026
Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
Principal investigator · Terminated · Phase 2
M.D. Anderson Cancer Center
2014–2017